UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 18, 2018

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in charter)

 

Florida		0-11102		59-1564329
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		I.R.S. Employer Identification No.)

 

4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314

(Address of principal executive offices) (Zip Code)

 

(954) 587-6280

Registrant’s telephone number, including area code:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company      ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders

 

Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 18, 2018. The proposals submitted by the Board of Directors to a vote of the shareholders, and the results of the voting on each proposal, are noted below.

 

Proposal No. 1 — Election of Directors.

 

The following nominees were elected by the shareholders to serve on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified:

 

Nominees		For				Withhold				Broker Non-Votes
Jeffrey S. Barocas			6,621,606				307,941				2,263,031
Diana Mazuelos Conard			6,857,741				71,806				2,263,031
Gregor M. Dornau			6,671,074				258,473				2,263,031
Peter G. Dornau			6,671,074				258,473				2,263,031
William W. Dudman			6,671,074				258,473				2,263,031
James M. Kolisch			6,661,071				268,473				2,263,031
Kimberly A. Krause			6,867,741				61,806				2,263,031
John B. Turner			6,857,491				72,056				2,263,031

  

Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.

 

The shareholders ratified the appointment of Accell Audit & Compliance, PA as the Company's independent registered public accounting firm for 2018. The voting results were as follows:

 

For				Against				Abstain				Broker Non-Votes
	6,031,643				-				-				2,263,031

 

Proposal No. 3 — Advisory Vote on the Compensation of our Named Executive Officers;

 

The shareholders approved, on an advisory basis, the compensation of our named executive officers. The voting results were as follows.

 

For				Against				Abstain				Broker Non-Votes
	6,903,266				24,990				1,291				2,325,033

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	OCEAN BIO-CHEM, INC.
Date: May 23, 2018	By:	/s/ Jeffrey S. Barocas
		Jeffrey S. Barocas
		Chief Financial Officer

 

 

2